These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20483193)

  • 1. Population-based analysis of Actinobacillus pleuropneumoniae ApxIVA for use as a DIVA antigen.
    O'Neilla C; Jones SCP; Bossé JT; Watson CM; Williamson SM; Rycroft AN; Simon Kroll J; Hartley HM; Langford PR
    Vaccine; 2010 Jul; 28(31):4871-4874. PubMed ID: 20483193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of apxIVA, a new RTX determinant of Actinobacillus pleuropneumoniae.
    Schaller A; Kuhn R; Kuhnert P; Nicolet J; Anderson TJ; Maclnnes JI; Segers RPAM; Frey J
    Microbiology (Reading); 1999 Aug; 145 ( Pt 8)():2105-2116. PubMed ID: 10463177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting genetic traits and epitope analysis of apxIVA in Actinobacillus pleuropneumoniae.
    Shin MK; Cha SB; Lee WJ; Yoo HS
    J Microbiol; 2011 Jun; 49(3):462-8. PubMed ID: 21717333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the apxIVA based PCR-REA method for differentiation of Actinobacillus pleuropneumoniae.
    Turni C; Blackall PJ
    Vet Microbiol; 2007 Mar; 121(1-2):163-9. PubMed ID: 17169508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influences of ORF1 on the virulence and immunogenicity of Actinobacillus pleuropneumoniae.
    Yuan F; Liu J; Guo Y; Tan C; Fu S; Zhao J; Chen H; Bei W
    Curr Microbiol; 2011 Dec; 63(6):574-80. PubMed ID: 21964939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of serovar-independent ELISA antigens of Actinobacillus pleuropneumoniae in pigs following vaccination or experimental challenge with respiratory pathogens and natural A. pleuropneumoniae serovar 1 challenge.
    Eamens GJ; Gonsalves JR; Whittington AM; Turner B
    Aust Vet J; 2012 Dec; 90(12):490-8. PubMed ID: 23186091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and detection of Actinobacillus pleuropneumoniae by PCR based on the gene apxIVA.
    Schaller A; Djordjevic SP; Eamens GJ; Forbes WA; Kuhn R; Kuhnert P; Gottschalk M; Nicolet J; Frey J
    Vet Microbiol; 2001 Mar; 79(1):47-62. PubMed ID: 11230928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of PCR based on gene apxIVA associated with 16S rDNA sequencing for the identification of Actinobacillus pleuropneumoniae and related species.
    da Costa MM; Klein CS; Balestrin R; Schrank A; Piffer IA; da Silva SC; Schrank IS
    Curr Microbiol; 2004 Mar; 48(3):189-95. PubMed ID: 15057463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ISApl1, a novel insertion element of Actinobacillus pleuropneumoniae, prevents ApxIV-based serological detection of serotype 7 strain AP76.
    Tegetmeyer HE; Jones SC; Langford PR; Baltes N
    Vet Microbiol; 2008 Apr; 128(3-4):342-53. PubMed ID: 18065168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of serovar-independent ELISA antigens of Actinobacillus pleuropneumoniae in pigs, following experimental challenge with A. pleuropneumoniae, Mycoplasma hyopneumoniae and Pasteurella multocida.
    Eamens GJ; Gonsalves JR; Whittington AM; Turner B
    Aust Vet J; 2012 Jun; 90(6):225-34. PubMed ID: 22632286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Actinobacillus pleuropneumoniae in pigs by real-time quantitative PCR for the apxIVA gene.
    Tobias TJ; Bouma A; Klinkenberg D; Daemen AJ; Stegeman JA; Wagenaar JA; Duim B
    Vet J; 2012 Aug; 193(2):557-60. PubMed ID: 22445313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination and protection of pigs against pleuropneumonia with a vaccine strain of Actinobacillus pleuropneumoniae produced by site-specific mutagenesis of the ApxII operon.
    Prideaux CT; Lenghaus C; Krywult J; Hodgson AL
    Infect Immun; 1999 Apr; 67(4):1962-6. PubMed ID: 10085043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cloning and expression of hemolytic-toxin from Actinobacillus pleuropneumoniae and the immunoprotection in mice].
    Du A; Diao Y; Zhang W; Zhang R; Zang D; Liu F
    Wei Sheng Wu Xue Bao; 2008 Mar; 48(3):342-8. PubMed ID: 18479061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo induced RTX toxin ApxIVA is essential for the full virulence of Actinobacillus pleuropneumoniae.
    Liu J; Chen X; Tan C; Guo Y; Chen Y; Fu S; Bei W; Chen H
    Vet Microbiol; 2009 Jun; 137(3-4):282-9. PubMed ID: 19251385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposal of a new serovar of Actinobacillus pleuropneumoniae: serovar 15.
    Blackall PJ; Klaasen HL; van den Bosch H; Kuhnert P; Frey J
    Vet Microbiol; 2002 Jan; 84(1-2):47-52. PubMed ID: 11731158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection.
    Maas A; Meens J; Baltes N; Hennig-Pauka I; Gerlach GF
    Vaccine; 2006 Nov; 24(49-50):7226-37. PubMed ID: 17027123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cloning and expression of the Apx IVA gene of Actionbacillus pleuroneumoniae and development of an indirect ApxIVA-ELISA].
    Huang HL; Zhou R; Chen ML; Liu JJ; Xu XJ; Chen HC
    Sheng Wu Gong Cheng Xue Bao; 2005 Mar; 21(2):294-9. PubMed ID: 16013493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposal of serovars 17 and 18 of Actinobacillus pleuropneumoniae based on serological and genotypic analysis.
    Bossé JT; Li Y; Sárközi R; Fodor L; Lacouture S; Gottschalk M; Casas Amoribieta M; Angen Ø; Nedbalcova K; Holden MTG; Maskell DJ; Tucker AW; Wren BW; Rycroft AN; Langford PR;
    Vet Microbiol; 2018 Apr; 217():1-6. PubMed ID: 29615241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel DNA Markers for Identification of Actinobacillus pleuropneumoniae.
    Srijuntongsiri G; Mhoowai A; Samngamnim S; Assavacheep P; Bossé JT; Langford PR; Posayapisit N; Leartsakulpanich U; Songsungthong W
    Microbiol Spectr; 2022 Feb; 10(1):e0131121. PubMed ID: 34985298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New trends in innovative vaccine development against Actinobacillus pleuropneumoniae.
    Loera-Muro A; Angulo C
    Vet Microbiol; 2018 Apr; 217():66-75. PubMed ID: 29615259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.